Bayer launches 'Breathless Moments' for CTEPH awareness; Sandoz wins Czech, Irish nods for Advair generic;

> Bayer has launched its "Breathless Moments" contest, which invites people to share photos of moments, events or sights that "take their breath away" in an effort to raise awareness of chronic thromboembolic pulmonary hypertension. More

> Novartis' ($NVS) Sandoz has won marketing authorization for AirFluSal Forspiro, a generic of GlaxoSmithKline's ($GSK) Advair, in Ireland and the Czech Republic. Report

> Eisai's cancer cookbook has won the ABPI Award for Excellence in Corporate Social Responsibility. More

> Keryx Biopharmaceuticals ($KERX) announced that the FDA has approved the trade name Auryxia for the company's ferric citrate. Release

> Raisio has acquired the Benecol business in the U.K., Ireland and Belgium from Cilag GmbH International, a Johnson & Johnson ($JNJ) affiliate. More

And Finally... Scientists at food company Nestlé are looking for a way to mimic the fat-burning effect of exercise--and put it in a bottle. More

Suggested Articles

After showing Nucala could cut the rates of flares for hypereosinophilic syndrome, GSK is planning regulatory filings in 2020.

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Both IL-17A inhibitors have rolled out data showing they work in non-radiographic axial spondyloarthritis.